P35 A collaborative approach to controlling an HIV outbreak among intravenous drug users

Gill Bell(Sheffield Teaching Hospitals NHS Foundation Trust), Rosemary McNaught, Caroline A. Evans(Biological E (India)), Timothy Devey(Sheffield Health and Social Care NHS Foundation Trust), O. Lagundoye(Sheffield Health and Social Care NHS Foundation Trust), Charlie Hughes(Sheffield Teaching Hospitals NHS Foundation Trust), A. Tunbridge(Sheffield Teaching Hospitals NHS Foundation Trust), Alison Cope(Sheffield Teaching Hospitals NHS Foundation Trust), S Naylor(Sheffield Teaching Hospitals NHS Foundation Trust), Julia Greig(Sheffield Teaching Hospitals NHS Foundation Trust)
Sexually Transmitted Infections
May 23, 2012
10.1136/sextrans-2012-050601c.35
Cited by 0

Related Papers

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
|The Lancet|2017|186
Supporting wellbeing in motor neurone disease for patients, carers, social networks, and health professionals: A scoping review and synthesis
|Palliative & Supportive Care|2017|34
Anakinra in the treatment of protracted paradoxical inflammatory reactions in HIV-associated tuberculosis in the United Kingdom: a report of two cases
|International Journal of STD & AIDS|2020|31
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial
|Trials|2012|27
The use of adjuvant granulocyte-macrophage colony-stimulating factor in HIV-related disseminated atypical mycobacterial infection
|Journal of Infection|2006|21